Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Immunotherapy”

496 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 496 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06620822
What this trial is testing

Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 296
Testing effectiveness (Phase 2)Ended earlyNCT05180006
What this trial is testing

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 33
Testing effectiveness (Phase 2)Looking for participantsNCT06444009
What this trial is testing

A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lei Liu 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231575
What this trial is testing

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Who this might be right for
Neoadjuvant ImmunotherapyNSCLCChemo-free Therapy
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Looking for participantsNCT05798845
What this trial is testing

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Chest Hospital 124
Early research (Phase 1)Looking for participantsNCT04323046
What this trial is testing

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioblastoma+3 more
Sabine Mueller, MD, PhD 20
Not applicableLooking for participantsNCT04973293
What this trial is testing

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasm Malignant
Ruijin Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05828381
What this trial is testing

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Who this might be right for
Immunotherapy;Envafolimab; Esophageal Cancer
Fujian Medical University Union Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT06617936
What this trial is testing

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Who this might be right for
Unresectable Non-small Cell Lung Cancer
Hua Zhang 36
Testing effectiveness (Phase 2)Looking for participantsNCT05507411
What this trial is testing

Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT05232916
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Who this might be right for
Breast Cancer
Greenwich LifeSciences, Inc. 750
Testing effectiveness (Phase 2)UnknownNCT05483439
What this trial is testing

Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

Who this might be right for
Stage II-III Breast Cancer
Shengjing Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814067
What this trial is testing

Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCC
Fudan University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05189730
What this trial is testing

Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 80
Not applicableStudy completedNCT05540145
What this trial is testing

Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)UnknownNCT05594381
What this trial is testing

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

Who this might be right for
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University 90
Not applicableStudy completedNCT06980350
What this trial is testing

Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 156
Testing effectiveness (Phase 2)Looking for participantsNCT06567782
What this trial is testing

Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer

Who this might be right for
Neoplasms, Colon
GlaxoSmithKline 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560
What this trial is testing

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Lei Zheng 25
Testing effectiveness (Phase 2)Looking for participantsNCT06114225
What this trial is testing

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

Who this might be right for
Osteosarcoma
Ruijin Hospital 43
Load More Results